- Home
- MCR vs MXCT Comparison
MCR vs MXCT Comparison
Compare MCR & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCR
- MXCT
- Stock Information
- Founded
- MCR 1989
- MXCT 1999
- Country
- MCR United States
- MXCT United States
- Employees
- MCR N/A
- MXCT N/A
- Industry
- MCR Trusts Except Educational Religious and Charitable
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MCR Finance
- MXCT Health Care
- Exchange
- MCR Nasdaq
- MXCT Nasdaq
- Market Cap
- MCR 266.0M
- MXCT 275.7M
- IPO Year
- MCR N/A
- MXCT 2021
- Fundamental
- Price
- MCR $6.01
- MXCT $2.73
- Analyst Decision
- MCR
- MXCT Strong Buy
- Analyst Count
- MCR 0
- MXCT 2
- Target Price
- MCR N/A
- MXCT $10.00
- AVG Volume (30 Days)
- MCR 66.7K
- MXCT 621.3K
- Earning Date
- MCR 01-01-0001
- MXCT 05-07-2025
- Dividend Yield
- MCR 8.52%
- MXCT N/A
- EPS Growth
- MCR N/A
- MXCT N/A
- EPS
- MCR 0.38
- MXCT N/A
- Revenue
- MCR N/A
- MXCT $38,627,000.00
- Revenue This Year
- MCR N/A
- MXCT $9.05
- Revenue Next Year
- MCR N/A
- MXCT $19.98
- P/E Ratio
- MCR $16.61
- MXCT N/A
- Revenue Growth
- MCR N/A
- MXCT N/A
- 52 Week Low
- MCR $5.63
- MXCT $2.21
- 52 Week High
- MCR $6.70
- MXCT $5.26
- Technical
- Relative Strength Index (RSI)
- MCR 38.98
- MXCT 47.09
- Support Level
- MCR $5.96
- MXCT $2.29
- Resistance Level
- MCR $6.07
- MXCT $2.74
- Average True Range (ATR)
- MCR 0.12
- MXCT 0.24
- MACD
- MCR -0.00
- MXCT 0.06
- Stochastic Oscillator
- MCR 56.13
- MXCT 88.14
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income. The fund invests the assets in debt instruments. It invests the assets in corporate bonds of U.S. and foreign issuers, U.S. Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S. and foreign issuers, and debt instruments of issuers located in emerging market countries.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.